Article
MYL2 is a potential diagnostic, prognostic, and immune biomarker for HNSC
2023-09-25
Abstract excerpt
<h4>Purpose: </h4> MYL2, a potential biomarker, is aberrantly expressed in a variety of tumor tissues. The purpose of this study was to determine the exact involvement of MYL2 in HNSC. Methods Massive bioinformatics analysiswere used to assess MYL2 mRNA and protein expression levels and its functional role in HNSC. Next, the prognostic effect of MYL2 on HNSC was analyzed using TCGA and GEPIA. Afterwards, the effe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b0a2d929-4e54-5dbd-a025-face22ae86cd
- DOI
- 10.21203/rs.3.rs-3366357/v1
